Health — Diabetes — February 17th, 2025

Diabetes fuels antibiotic resistance, worsening infections and treatment challenges
Diabetes mellitus (DM) affects about 530 million people globally, with current estimates projecting that DM cases will reach 1.3 billion by 2050. Individuals with DM are at an increased risk of skin and soft tissue infections (SSTIs) that are difficult to treat, even with antibiotics.
February 17, 2025 — Source

Inadequate postpartum screening for hypertension and diabetes a 'missed opportunity' for women, study suggests
Less than one in five patients are tested for cardiovascular risk factors following pregnancy-related hypertension or diabetes, according to a new study published in the "Go Red for Women" issue of Circulation.
February 17, 2025 — Source

Health — Diabetes — February 14th, 2025

Self-sealing, atomically thin dialysis membranes: Proteins transform leakage into filtration advantage
A Vanderbilt-led research team has made a significant breakthrough in developing advanced dialysis membranes using atomically thin materials like graphene. These innovative membranes, called nanoporous atomically thin membranes (NATMs), leverage a protein-enabled sealing mechanism to address a key challenge in dialysis technology, which is maintaining high efficiency in filtering small molecules while minimizing protein loss.
February 14, 2025 — Source

Health — Diabetes — February 5th, 2025

Drinking ketones improves heart health for people with type 2 diabetes
Drinking ketones improves heart health, a new small-scale study from the University of Portsmouth has found.
February 5th, 2025 — Source

Fruit fly research reveals new insights into insulin production
The hormone insulin plays a central role in the metabolism of many living organisms. When food is plentiful, insulin promotes the absorption and storage of energy. In times of hunger, however, insulin secretion is reduced; the body conserves energy or searches for alternative energy sources. It is crucial for survival that this system is finely tuned. If it gets out of balance, there is a risk of diabetes and other metabolic diseases.
February 5th, 2025 — Source

Rapid increase in early-onset type 2 diabetes in China highlights urgent public health challenges
A study led by researchers from Peking University and published in Health Data Science reveals a sharp rise in the burden of early-onset type 2 diabetes (T2D) among adolescents and young adults in China from 1990 to 2021. Despite improvements in mortality rates, the incidence and disability-adjusted life years (DALYs) associated with the disease have grown alarmingly.
February 5th, 2025 — Source

Health — Diabetes — February 3rd, 2025

New, increasingly widely used diabetes medication may have additional health benefits for older adults
A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new research which looked at data from more than 300,000 patients who have taken part in clinical trials.
February 3rd, 2025 — Source

Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs
Monthly prescriptions for obesity medications reached 1.5 million in February 2024, with semaglutide (Wegovy) and tirzepatide (Zepbound) gaining market share as phentermine's dominance declines
February 3rd, 2025 — Source

Health — Diabetes — January 24th, 2025

Circulating short-chain fatty acids are associated with type 2 diabetes risk
Short-chain fatty acids (SCFAs) serve as key signaling molecules linking gut microbiota and host health. Microbially produced SCFAs in the colon are generally acknowledged for their beneficial effects on cardiometabolic health, including enhancing insulin secretion, reducing plasma cholesterol and glucose levels, and controlling energy intake through the modulation of enteroendocrine hormones.
January 24th, 2025 — Source

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity
A multicentre trial in China finds that combining SGLT-2 inhibitors with calorie restriction improves remission, weight loss, and metabolic health without added adverse effects
January 24th, 2025 — Source

Study links circulating short-chain fatty acids to type 2 diabetes risk
Short-chain fatty acids (SCFAs) serve as key signaling molecules linking gut microbiota and host health. Microbially produced SCFAs in the colon are generally acknowledged for their beneficial effects on cardiometabolic health, including enhancing insulin secretion, reducing plasma cholesterol and glucose levels, and controlling energy intake through the modulation of enteroendocrine hormones. Indeed, microbially produced SCFAs have been shown to reach the systemic circulation at micromolar concentrations, which is more directly linked to metabolic health parameters rather than its levels in the colon.
January 24th, 2025 — Source

Health — Diabetes — January 22nd, 2025

Editing embryos to prevent genetic diseases: Study sparks ethical debate
Scientists from a collaboration of Australian research institutions have proposed that editing multiple genetic variants in human embryos could significantly lower the likelihood of developing complex diseases such as coronary artery disease, Alzheimer's, major depressive disorder, diabetes, and schizophrenia.
January 22nd, 2025 — Source

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity
Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been linked with behavioral side effects. A large population-based analysis in Diabetes, Obesity and Metabolism assessed whether certain genetic variants might help explain these effects.
January 22nd, 2025 — Source

Why do people with obesity, but without diabetes, start taking semaglutide?
Factors such as sex, type of insurance plan, and the use of common medications influenced whether individuals with obesity but without diabetes initiated semaglutide treatment
January 22nd, 2025 — Source

Health — Diabetes — January 20th, 2025

Lower blood pressure for diabetic patients can reduce cardiovascular disease
People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovascular disease when their blood pressure was lower than the current standard goal, a UT Southwestern Medical Center researcher and his colleagues found.
January 20th, 2025 — Source

Many Greenlanders face 10 times higher risk of diabetes—exercise may be their only solution
A significant portion of the Greenlandic Inuit population carries a genetic variant that increases their risk of type 2 diabetes tenfold. Now, researchers from the University of Copenhagen have discovered that the key to addressing this issue lies solely in their muscles. Unfortunately, existing medications are unlikely to help—and in fact may even do more harm than good. On the other hand, the study reveals that physical exercise could have a positive effect.
January 20th, 2025 — Source

Study explores waist circumference's link to mortality risk in diabetic individuals
Waist circumference (WC) is closely associated with metabolic diseases, including diabetes mellitus (DM), metabolic syndrome, and mortality. However, the correlation between WC and mortality varies across populations and has rarely been examined specifically in patients with DM. In this study, we explored the relationships between WC and both all-cause and cardiovascular mortalities among individuals with DM.
January 20th, 2025 — Source

Health — Diabetes — January 17th, 2025

Intestinal bacterium found to reduce sugar intake in diabetic mice and humans
Excessive sugar consumption is linked to several non-communicable diseases, including obesity, cardiovascular disease, metabolic syndrome, and type 2 diabetes. Animals naturally crave sugar, and uncontrolled sugar preferences can lead to high sugar intake, raising the risk of hyperglycemia and metabolic diseases.
January 17th, 2025 — Source

Meet 'Super' Ozempic: Higher Dose Semaglutide Leads to Even Greater Weight Loss In Major Trial
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
January 17th, 2025 — Source

New animal model offers insights into pancreatic disease and diabetes
Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction representing a critical and often overlooked complication. A recent study published in eGastroenterology introduces young rabbits with CF as a novel and accessible model to study CF-related pancreatic endocrine pathology. This model offers an unprecedented opportunity to deepen our understanding of CF-related diabetes (CFRD), a condition affecting up to 50% of adults with CF.
January 17th, 2025 — Source

Q&A: Transplant treatment for diabetes shows promising results
A completely new way of treating type 1 diabetes is being tested at Uppsala University Hospital. Patients are being offered transplants of genetically modified insulin-producing cells and the initial results are promising. We put a few questions to Per-Ola Carlsson, Professor of Medical Cell Biology, who is leading the study.
January 17th, 2025 — Source

Researchers find association between elevated levels of protein VEGF-B and impaired kidney function
In diabetic kidney disease, fat accumulates in the kidneys, leading to lipotoxicity and kidney damage. A recently published study by Ulf Eriksson's research group at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet shows that elevated levels of the protein VEGF-B in the kidney and adipose tissue correlate with increased fat accumulation in the kidney and impaired kidney function in patients with diabetic kidney disease.
January 17th, 2025 — Source

Wegovy and Ozempic top list of 15 drugs up for next price negotiations
If the Trump admin doesn't alter the process, negotiated prices will go into effect in 2027.
January 17th, 2025 — Source

Health — Diabetes — January 13th, 2025

Early-life gut microbes may protect against diabetes, research in mice suggests
The microbiome shapes the development of insulin-producing cells in infancy, leading to long-term changes in metabolism and diabetes risk, new research in mice has found.
January 13th, 2025 — Source

How AI could supercharge your glucose monitor - and catch other health issues
Stanford researchers built an algorithm to predict subtypes of Type 2 diabetes that works right from your home.
January 13th, 2025 — Source

Improved trends in anti-diabetic medication reduce severe complications
Researchers from the University of California, Irvine, were the first to report an improvement in severe diabetes-related acute complications, such as dangerously low blood sugar that led to emergency room visits or hospitalizations, among American Indian and Alaska Native (AI/AN) adults with Type 2 diabetes.
January 13th, 2025 — Source

Special gut bacterium could help cut sugar cravings
Researchers have identified a gut bacterium that may be associated with reduced dietary sugar intake. The findings, which are based on analyses of humans and mice, could aid the development of therapies to manage obesity and metabolic diseases, such as type 2 diabetes.
January 13th, 2025 — Source

What to do if you miss a dose of GLP-1
Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug—better known as GLP-1—for weight loss, the protocol for getting back on track may be different from missing a dose of antibiotics.
January 13th, 2025 — Source

Health — Diabetes — January 10th, 2025

Higher radon exposure linked to increased odds of gestational diabetes
In nulliparous pregnant individuals, higher radon exposure is associated with greater odds of gestational diabetes (GD), according to a study published online Jan. 10 in JAMA Network Open.
January 10th, 2025 — Source

Health — Diabetes — January 9th, 2025

Oral glucose-lowering agents are potential alternatives to insulin for gestational diabetes
With respect to the proportion of infants born large for gestational age, treatment of gestational diabetes with metformin and glyburide, if needed, does not meet the criteria for noninferiority versus insulin, according to a study published in the Journal of the American Medical Association.
January 9th, 2025 — Source or Source

Statistical model analyzes the cost-effectiveness of semaglutide for non-diabetic obese individuals
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows. However, with price reductions or rebates up to 50%, it could meet the benchmark for value in healthcare. An article in the Canadian Journal of Cardiology, published by Elsevier, details a statistical model analyzing the cost-effectiveness of semaglutide.
January 9th, 2025 — Source

Health — Diabetes — January 8th, 2025

Best Glucose Meter for Diabetes and Blood Sugar Monitoring
Keep tabs on your blood sugar to manage your diabetes with the best glucose meters of 2025.
January 8th, 2025 — Source

Carrots may aid in managing type 2 diabetes, study suggests
Could an ordinary carrot improve the treatment of type 2 diabetes? A new study from SDU suggests so. The researchers found that carrots can enhance the body's ability to regulate blood sugar and positively influence the composition of gut bacteria.
January 8th, 2025 — Source

Fecal transplant shows promise for diabetic gastroenteropathy treatment
A newly published study from Aarhus University Hospital shows that fecal microbiota transplantation (FMT)—a method where gut bacteria from healthy donors are transferred to patients—can be a safe and effective treatment for patients with type 1 diabetes and gastroenteropathy
January 8th, 2025 — Source

How a protein affects the ability to secrete insulin in type 2 diabetes
In type 2 diabetes, the body's ability to release insulin is impaired, which leads to high blood glucose levels. Research led by Lund University shows how the levels of a particular protein are elevated in the pancreas of people with type 2 diabetes. By knocking out the gene for the protein IGFBP7, the researchers discovered that insulin secretion improved.
January 8th, 2025 — Source

Liver protein SerpinA1: A new player in the fight against obesity and diabetes
Researchers from Kumamoto University have identified a liver-derived protein, serine protease inhibitor A1 (SerpinA1), as a key regulator in combating obesity and enhancing glucose metabolism.
January 8th, 2025 — Source

Health — Diabetes — January 7th, 2025

AI uses simple glucose monitor data to predict and identify subtypes of type 2 diabetes
Diabetes has long been lumped into two categories—type 1, which often appears in childhood, or type 2, which is associated with obesity and typically develops later in life. But scientists have learned that not all patients with type 2 diabetes are the same, with some patients varying in body weight, age of onset and other characteristics.
January 7th, 2025 — Source

Childhood racial segregation in school tied to late-life cognitive outcomes
Childhood exposure to school segregation is associated with worse late-life cognitive outcomes among older Black adults, according to a study published online Jan. 3 in JAMA Network Open.
January 7th, 2025 — Source

Denosumab found to increase cardiovascular risk in dialysis-dependent patients
For dialysis-dependent patients treated for osteoporosis, denosumab is associated with a greater preventive effect on fractures but an increased risk for major adverse cardiovascular events (MACE) compared with oral bisphosphonates, according to a study published online Jan. 7 in the Annals of Internal Medicine.
January 7th, 2025 — Source

GLP-1 drugs may reduce surgery complications in patients with diabetes
People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after surgery, according to a large study led by investigators at Weill Cornell Medicine, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian.
January 7th, 2025 — Source or Source

Sugar-sweetened drinks linked to 1 in 10 new diabetes cases
Global study links sugar-sweetened beverages to millions of diabetes and heart disease cases, with developing regions facing the greatest burden
January 7th, 2025 — Source

Two OTC continuous glucose monitors won awards at CES - and you can try them now
These over-the-counter CGMs from health brands Dexcom and Abbott make glucose monitoring affordable and accessible. Here's how they can help you - no prescription necessary.
January 7th, 2025 — Source

Health — Diabetes — January 6th, 2025

Global study links millions of diabetes and heart disease cases to sugary drinks
A new study from researchers at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University, published in Nature Medicine, estimates that 2.2 million new cases of type 2 diabetes and 1.2 million new cases of cardiovascular disease occur each year globally due to consumption of sugar-sweetened beverages.
January 6th, 2025 — Source or Source

Health — Diabetes — January 3rd, 2025

National Diabetes Prevention Program helps reduce medical costs
About 1 in 3 adults in the United States have prediabetes, a condition where blood glucose levels are higher than normal, but not high enough to be diagnosed as diabetes.
January 3rd, 2025 — Source

Social connections may boost immunity and reduce disease risk
Interactions with friends and family may keep us healthy because they boost our immune system and reduce our risk of diseases such as heart disease, stroke and type 2 diabetes, new research suggests.
January 3rd, 2025 — Source

Surveys reveal National Diabetes Prevention Program saves costs for enrollees
About 1 in 3 adults in the United States have prediabetes, a condition where blood glucose levels are higher than normal, but not high enough to be diagnosed as diabetes.
January 3rd, 2025 — Source

Health — Diabetes — December 31st, 2024

Pain coping skills training beneficial during maintenance hemodialysis
Pain coping skills training (PSCT) is beneficial for patients undergoing maintenance hemodialysis and experiencing chronic pain, according to a study published online Dec. 30 in JAMA Internal Medicine.
December 31st, 2024 — Source

Health — Diabetes — December 27th, 2024

FDA approves first generic liraglutide once-daily injection
The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes.
December 27th, 2024 — Source

Health — Diabetes — December 25th, 2024

Eating red meat may increase your risk of type 2 diabetes—not a lot of people know that
Red meat has been a part of diets worldwide since early man. It is an excellent source of protein, vitamins (such as B vitamins) and minerals (such as iron and zinc).
December 25th, 2024 — Source

Health — Diabetes — December 20th, 2024

Loosening chimeric antigen receptor's grip on T-regulatory cells improves function, researchers find
A new paper from MUSC Hollings Cancer Center researchers is helping to reveal the "rules" for engineering chimeric antigen receptor (CAR) Tregs.
December 20th, 2024 — Source

Health — Diabetes — December 16th, 2024

Hot tub therapy offers hope for people with type 2 diabetes
Hot tubs can improve insulin effectiveness, heart health and lower blood pressure in people with type 2 diabetes, research from the University of Portsmouth has found.
December 16th, 2024 — Source

Weight-loss drugmaker Novo Nordisk invests $1.2 bn in new factory in Denmark
Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was investing 8.5 billion kroner ($1.2 billion) to build a new factory in Denmark to produce drugs against rare diseases.
December 16th, 2024 — Source

Health — Diabetes — December 10th, 2024

Empathetic calls improve diabetes control in low-income adults, study finds
Empathy-focused phone calls made by trained, nonmedical community members led to significant improvements in blood sugar control for low-income adults with diabetes, according to a new study from Dell Medical School at The University of Texas at Austin in collaboration with Lone Star Circle of Care.
December 10th, 2024 — Source

New international guideline on diabetes and exercise
Professor Dr. Othmar Moser from the University of Bayreuth is the lead author of the new international guideline on exercise and type 1 diabetes. A total of 26 international authors contributed to the December 10th, 2024 — Source

Researchers unlock new gene therapy targets for diabetic kidney disease
New potential therapeutic targets have been identified for diabetic kidney disease (DKD)—the leading cause of kidney failure in the world—that could see patients treated with new gene and drug therapies preventing the disease's progression into end stage kidney failure.
December 10th, 2024 — Source

Sweet news: Dark chocolate reduces type 2 diabetes risk
US cohort study highlights dark chocolate's potential role in reducing type 2 diabetes risk, while milk chocolate consumption is associated with weight gain.
December 10th, 2024 — Source

Health — Diabetes — December 6th, 2024

Five servings of dark chocolate a week may protect against type 2 diabetes
Eating five servings of dark chocolate a week is associated with a reduction in the risk of type 2 diabetes, according to a long-term US study published by The BMJ today.
December 6th, 2024 — Source

Researchers in Japan discover new antidiabetic compound
Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes treatment innovation.
December 6th, 2024 — Source

Health — Diabetes — December 2nd, 2024

An affordable and effective nutritional approach to help reduce inflammation and prevent type 2 diabetes
A team sheds new light on the role of marine-source omega-3 supplementation in treating adipose tissue inflammation and reducing the risk for cardiometabolic diseases like type 2 diabetes.
December 2nd, 2024 — Source

Health — Diabetes — November 27th, 2024

208 million Americans are classified as obese or overweight, according to new study on 132 data sources
Nearly half of adolescents and three-quarters of adults in the U.S. were classified as being clinically overweight or obese in 2021. The rates have more than doubled compared with 1990.
November 27th, 2024 — Source

Food additive carrageenan could disrupt intestinal barrier and increase risk of type 2 diabetes
The food additive carrageenan (E 407) can be responsible for the development of chronic inflammatory bowel disease, ulcers, and increased blood sugar levels in animals. However, it is not yet known what effect carrageenan has on the risk of developing type 2 diabetes in humans.
November 27th, 2024 — Source or Source

How sweet is it really? Non-nutritive sweeteners and the control of blood sugar levels
Non-nutritive sweeteners are often perceived as healthier than sugar, but new findings have confirmed new ways they may interact with sugar handling in the body.
November 27th, 2024 — Source

No 'one size fits all' treatment for Type 1 Diabetes
Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study has found.
November 27th, 2024 — Source

Study finds unexpected patterns in insulin needs for type 1 diabetes
Factors beyond carbohydrates have a substantial influence on blood glucose levels meaning current automated insulin delivery systems miss vital information required for glucose regulation, a new study has found.
November 27th, 2024 — Source

World's most common heart valve disease linked to insulin resistance
A large population study of men over 45 indicates insulin resistance may be an important risk factor for the development of the world's most common heart valve disease—aortic stenosis (AS).
November 27th, 2024 — Source or Source

Health — Diabetes — November 25th, 2024

Bioengineering strategy uses immune-protected beta cell transplant to advance type 1 diabetes care
Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no longer have to rely on donors. Organ shortages and cell type mismatches will become past problems, replaced by safe, on-demand options for anyone who needs a transplant.
November 25th, 2024 — Source

Taking a GLP-1 medication? Expert offers tips for holiday eating
So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where decadent food will be served in abundance.
November 25th, 2024 — Source

Health — Diabetes — November 23rd, 2024

Lingo CGM Review: Why I'm Still Sweet on the Idea of Everyone Checking Their Blood Sugar
You don't need to wait for Apple to add glucose sensing to a smartwatch. Biosensors give you real-time data, and you no longer require a prescription.
November 23rd, 2024 — Source

More than half of US adults could benefit from GLP-1 medications, researchers find
In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults, more than half of all adults, are eligible for semagludtide for weight loss, diabetes management, or prevention of recurrent cardiovascular events.
November 23rd, 2024 — Source

Health — Diabetes — November 21st, 2024

New hope for diabetic heart disease treatment
Drug discovery researchers have found that a natural fat molecule called 'lipoxin A4' (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.
November 21st, 2024 — Source

Nerve damage reduced in prediabetic mice with diet, exercise
A low calorie diet and high intensity exercise can reduce nerve damage in prediabetic mice, according to a Michigan Medicine study.
November 21st, 2024 — Source

Health — Diabetes — November 18th, 2024

Diabetes drug shows promise in protecting kidneys
Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led research group has investigated how such drugs maintain kidney health.
November 18th, 2024 — Source

Diabetes meds metformin and GLP-1s can also curb asthma, research finds
Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British research shows.
November 18th, 2024 — Source

GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential for novel treatments pending further clinical trials.
November 18th, 2024 — Source

Intensive blood pressure treatment reduces cardiovascular risk in people with Type 2 diabetes
An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk of heart attack, stroke, heart failure and death due to cardiovascular disease when compared to a standard treatment approach, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2024.
November 18th, 2024 — Source

Patients with diabetes are as satisfied with telehealth as with in-person care
A University of Florida study finds that people with diabetes who participate in telehealth doctor visits report the same level of quality of care, trust in the health care system, and patient-centered communication as patients who receive care through in-person visits.
November 18th, 2024 — Source

Proactively screening diabetes patients for heart disease does not improve long-term survival
While coronary heart disease and diabetes are often seen in the same patients, a diagnosis of diabetes does not necessarily mean that patients also have coronary heart disease, according to a new study from researchers at Intermountain Health in Salt Lake City.
November 18th, 2024 — Source

Rare variant analysis reveals genetic spectrum of monogenic diabetes genes
Genetic research uncovers a continuum between diabetes forms, offering insights for precision medicine.
November 18th, 2024 — Source

Screening diabetics for heart disease does not improve long-term mortality rates, reduce future cardiac events: Study
While coronary heart disease and diabetes are often seen in the same patients, a diagnosis of diabetes does not necessarily mean that patients also have coronary heart disease, according to a new study by researchers at Intermountain Health in Salt Lake City.
November 18th, 2024 — Source

'Staggeringly high' discontinuation rates for GLP-1 drugs like Ozempic or Wegovy
The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with 12% of U.S. adults having used one despite the high cost, according to a June 2024 poll.
November 18th, 2024 — Source

Tirzepatide yields sustained weight reduction in obesity and prediabetes, finds study
For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study published in the New England Journal of Medicine.
November 18th, 2024 — Source

Health — Diabetes — November 17th, 2024

Best Vitamins and Supplements for Joint Health in 2024
To support your joint health as you age, talk to your doctor about these vitamins and supplements.
November 17th, 2024 — Source

Lingo CGM Review: Why I'm Still Sweet on the Idea of Everyone Checking Their Blood Sugar
You don't need to wait for Apple to add glucose sensing to a smartwatch. Biosensors give you real-time data, and you no longer require a prescription.
November 17th, 2024 — Source

Risk for mortality up with low income in type 2 diabetes
Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years, according to a study published online Nov. 12 in JAMA Network Open.
November 17th, 2024 — Source

Health — Diabetes — November 15th, 2024

Diabetes medication may be effective in helping people drink less alcohol, research finds
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use.
November 15th, 2024 — Source orSource or Source

Global gap in diabetes prevalence and treatment has widened since 1990
Since 1990, rising diabetes rates in lower-income countries have outpaced improvements in care, while wealthier nations have seen the greatest treatment advances, widening the global diabetes gap.
November 15th, 2024 — Source

Innovative islet transplant method reduces surgical complications for type 1 diabetes
An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of Biomedical Engineering at UNIST. They have developed a novel pancreatic islet macroencapsulation system designed for subcutaneous transplantation, offering a promising solution for type 1 diabetes management.
November 15th, 2024 — Source

Health — Diabetes — November 12th, 2024

High-precision wearable devices identify impact of gestational diabetes
A common complication linked with pregnancy, gestational diabetes increases the risk of developing metabolic disorders, such as type 2 diabetes. Yet, its effects after childbirth remain poorly understood.
November 12th, 2024 — Source

Health — Diabetes — November 8th, 2024

Flagship AI-ready dataset released in type 2 diabetes study
Early results suggest broader participant diversity and novel measures will enable new, artificial intelligence-driven insights
November 8th, 2024 — Source or Source

Mediterranean diet may reduce type-2 diabetes risk in fatty liver patients
High adherence to the Mediterranean diet may lower T2DM risk in MAFLD patients, especially men without weight gain, supporting dietary recommendations.
November 8th, 2024 — Source

Health — Diabetes — November 7th, 2024

Lithuanian scientists develop non-invasive device to improve blood circulation
Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent complications of diabetes, called diabetic foot. A syndrome characterized by foot ulcers, often associated with infection, it is the leading cause of hospitalization and up to 30 percent of amputations.
November 7th, 2024 — Source

Novo Nordisk CEO warns of deaths linked to compounded semaglutide
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least 100 hospitalizations and 10 deaths.
November 7th, 2024 — Source

Research links self-efficacy to better diabetes management in adolescents
Self-efficacy involves one's belief in their own ability to carry out tasks successfully. A psychological construct studied by psychologist Albert Bandura since the 1980s, it has been shown to have an influence not only on cognitive processes, but also on behavior and emotions. According to a recently published study, this confidence in achieving goals generates behavioral changes that improve glycemic control of type I diabetes in adolescents. The key is those behavioral changes.
November 7th, 2024 — Source

Health — Diabetes — November 2nd, 2024

Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study finds
Rutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance.
November 2nd, 2024 — Source

Health — Diabetes — November 1st, 2024

Certain diabetes drugs linked to lower risk of kidney stones and gout
Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada published by BMJ.
November 1st, 2024 — Source

Porous dermal fillers show promise for diabetic wound treatment
Researchers have developed a revolutionary injectable granular filler that could transform the way diabetic wounds are treated, potentially improving patient outcomes. The groundbreaking study introduced an innovative approach about using specialized porous dermal fillers that accelerate tissue healing and regeneration.
November 1st, 2024 — Source

Vasomotor symptoms during menopause may up risk for type 2 diabetes
Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D), according to a research letter published online Oct. 31 in JAMA Network Open.
November 1st, 2024 — Source

Health — Diabetes — October 30th, 2024

Study suggests women entering menopause later in life at greater risk for asthma
Many studies suggest that an earlier age at menopause is more detrimental to a woman's health, leading to an increased risk for adverse health conditions such as heart disease, diabetes, osteoporosis, and depression, among others. However, a new study is linking a later age at natural menopause with a greater risk for asthma.
October 30th, 2024 — Source

Health — Diabetes — October 28th, 2024

Off-label glucose-lowering drugs may put type 1 diabetes patients at risk

A collaboration of researchers led by Emory University Rollins School of Public Health, Atlanta, is urging caution when prescribing off-label glucose-lowering drugs to individuals with type 1 diabetes (T1D).
October 28th, 2024 — Source

Study finds breastfeeding lowers cardiovascular risk in women with type 2 diabetes and gestational diabetes

Researchers found that women who breastfed showed much lower rates of cardiovascular disease (CVD) and longer duration of breastfeeding was associated with lower risk of CVD in women with type 2 diabetes or gestational diabetes (GDM). The researchers are from the Global Centre for Asian Women's Health or GloW, based at the NUS Yong Loo Lin School of Medicine (NUS Medicine) and Harvard T.H. Chan School of Public Health.
October 28th, 2024 — Source

Health — Diabetes — October 25th, 2024

Apple continues focus on blood-sugar tracking, including noninvasive glucose monitoringApple, seeking to make further inroads in health care, tested a blood sugar tracking app this year to help people with prediabetes manage their food intake and make lifestyle changes, Mark Gurman reports for Bloomberg News citing "people with knowledge of the matter."

#2693
October 25th, 2024 — Source or Source or Source

Bariatric surgery decline tied to rise in GLP-1 drugs to treat obesity
A new study by researchers at Brigham and Women's Hospital in collaboration with researchers at Harvard T.H. Chan School of Public Health and the Brown School of Public Health, examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications more than doubled from 2022 to 2023.
October 25th, 2024 — Source

Semaglutide may reduce Alzheimer's risk in diabetics
Semaglutide linked to 40-70% lower risk of first-time Alzheimer's diagnosis in type 2 diabetes patients compared to other antidiabetic medications.
October 25th, 2024 — Source

Health — Diabetes — October 22nd, 2024

Modeling diabetes in minipigs for more accurate testing of potential cell therapies

Since the discovery of human iPS cells, a principal goal for researchers worldwide has been to use them for various medical applications, including cell therapy. Among different human diseases, type 1 diabetes mellitus (T1DM) has been a top priority for cell therapy development.
October 23rd, 2024 — Source

New anti-obesity drug shows promise in preventing heart failure related to type 2 diabetes

A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic heart function in mice with type 2 diabetes independent of its weight loss effects, suggesting the drug may work as a treatment to prevent the most prevalent form of heart failure in people with diabetes.
October 23rd, 2024 — Source

People with type 2 diabetes who eat low-carb may be able to discontinue medication

Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function, allowing them to better manage their disease and possibly discontinue medication, according to new research published in the Journal of Clinical Endocrinology & Metabolism.
October 23rd, 2024 — Source

TikTok diagnosed creator with Type 1 diabetes before his doctor did

TikTok isn't the first place I'd think of in relation to the concept of the wisdom of crowds, but it seems I may be underestimating the streaming video app ...
October 23rd, 2024 — Source

Type 1 diabetes FAQs

Endocrinologist Yogish Kudva, M.B.B.S., answers the most frequently asked questions about type 1 diabetes.
October 23rd, 2024 — Source or Watch Video

Type 2 diabetes patients may benefit from reduced carbohydrate intake

Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease and possibly discontinue medication, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
October 23rd, 2024 — Source

Health — Diabetes — October 18th, 2024

Researchers Develop Eye Scanner That Spots Signs of Diabetes, Heart Disease, Alzheimer's
One eye scanner to detect them all.
October 18th, 2024 — Source

Health — Diabetes — October 16th, 2024

New type of insulin that switches on and off could help diabetics avoid sudden drops in blood sugar levels
A modified insulin that can prevent sudden drops in blood sugar has been demonstrated in laboratory experiments and animal models, reports a paper in Nature. This could provide a more flexible way to supplement insulin for individuals with diabetes and reduce sudden drops in blood glucose.
October 16th, 2024 — Source

Health — Diabetes — October 8th, 2024

How diabetes-risk genes make cells less resilient to stress
Researchers have now discovered that DNA sequence changes known to increase a person's risk for diabetes are linked to how well pancreatic cells can handle two different kinds of molecular stress. In people with these DNA changes, the insulin-producing cells in the pancreas may be more likely to fail or die when exposed to stress and inflammation.
October 8th, 2024 — Source or Source

Mounjaro will soon be available as a weight loss treatment on the NHS. Here's what that means for patients
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice). Previously, it was only available on the NHS for patients with diabetes.
October 8th, 2024 — Source

Research suggests a new strategy for people with type 1 diabetes to lower blood sugar after exercise
Adults with type 1 diabetes should perform aerobic cooldowns to manage high blood sugar after intense exercise where glucose levels might rise, according to current guidelines for managing the disease. However, this recommendation has never been empirically tested—and recent research from the University of Alberta could offer a better solution.
October 8th, 2024 — Source

Study shows adolescence and young adulthood are risky periods for those living with diabetes
For young people living with diabetes in Quebec, adolescence and young adulthood are periods marked by a significantly higher risk of interruptions in clinical care, hospitalizations and emergency room visits, reveals a study conducted by researchers at the Research Institute of the McGill University Health Centre (RI-MUHC). These alarming findings highlight the need to improve care for youth living with diabetes during this pivotal period of their lives.
October 8th, 2024 — Source

Health — Diabetes — October 6th, 2024

What Can Your Blood Sugar Tell You? I Tracked Mine for a Month to Find Out
Biosensors that measure glucose are now available without a prescription. Wearing one nearly burst my wellness bubble.
October 6th, 2024 — Source

Health — Diabetes — September 25th, 2024

I Tracked My Blood Sugar for a Month. It Burst My Wellness Bubble
Biosensors that measure glucose are now available without a prescription. Wearing one was an emotional roller coaster ride.
September 25th, 2024 — Source

Novel regulator of glucose transport in adipose tissue discovered
The role of the adapter protein PICALM (phosphatidylinositol-binding clathrin assembly protein) in the development of Alzheimer's disease is well documented. Researchers from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), the German Center for Diabetes Research (DZD), ETH Zurich and the University of Cambridge have now for the first time studied the role of PICALM in white adipose tissue and its importance for metabolic health.
September 25th, 2024 — Source

Health — Diabetes — September 23rd, 2024

Research reveals disparities in diabetes drug efficacy for Black populations
New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations. Cardiovascular disease is the leading cause of severe illness and death associated with type 2 diabetes. Renal disease is also a common complication of type 2 diabetes.
September 23rd, 2024 — Source

Health — Diabetes — September 16th, 2024

Reducing ultra-processed foods can lower type 2 diabetes risk
People who eat more ultra-processed foods (UPF) are at increased risk of developing type 2 diabetes, but this risk can be lowered by consuming less processed foods instead, finds a new study led by researchers at UCL.
September 16th, 2024 — Source

Social determinants of health associated with diabetic eye-care quality
Patients who live in rural communities, Hispanic patients and Black patients with pre-existing diabetic retinopathy are less likely to receive annual diabetic eye exams than white patients, according to a recent Northwestern Medicine study published in JAMA Ophthalmology.
September 16th, 2024 — Source

Study finds replacing ultra-processed foods in diet reduces type 2 diabetes risk
People who eat more ultra-processed foods (UPF) are at increased risk of developing type 2 diabetes, but this risk can be lowered by consuming less processed foods instead, finds a new study led by researchers at UCL.
September 16th, 2024 — Source

Health — Diabetes — September 13th, 2024

Cellular map of the pancreas could lead to better treatments against pancreatic cancer and diabetes
Pancreatic diseases, such as diabetes or pancreatic cancer, are usually severe and have a strong impact on patients. Unfortunately, today, there are no specific or effective treatments for pancreatic cancer, so the survival rate of patients is very low. In the case of diabetes, the development of new cell replacement therapies for insulin-producing cells seems to be the future cure of insulin-dependent patients.
September 13th, 2024 — Source

Health — Diabetes — September 10th, 2024

Common diabetes drug slows growth of normal cells carrying cancer mutation, finds study
A common diabetes medication, metformin, slows the growth of precancerous cells in the esophagus while some metabolic conditions accelerate it, suggests a new study.
September 10th, 2024 — Source

Novel class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes, new study finds
New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9--13 Sept) shows that a new class of insulin that is injected once a week is as effective as daily insulin injections for effective and safe blood sugar management in patients with type 2 diabetes.
September 10th, 2024 — Source

Health — Diabetes — September 9th, 2024

Eating fruit, oats and rye in childhood may increase type 1 diabetes risk
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), shows that eating fruit, oats and rye in childhood is associated with a higher risk of developing type 1 diabetes (T1D). Eating berries, however, is linked to lower odds of developing the condition.
September 9th, 2024 — Source

Insulin resistance linked to 31 diseases and higher early death risk in women
Insulin resistance is associated with 31 different diseases and, in women, is also linked to higher odds of an early death, a study of data on hundreds of thousands of people in the UK being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.
September 9th, 2024 — Source

New hydrogel system could extend semaglutide dosing to once a month for type 2 diabetes patients
French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once a month, according to new research to be presented at this year's annual meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
September 9th, 2024 — Source

Night owls have higher BMI, larger waists and face higher risk of type 2 diabetes
Night owls have a higher BMI, larger waists, more hidden body fat and are almost 50% more likely to develop type 2 diabetes (T2D) than those who go to bed earlier, new research to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.
September 9th, 2024 — Source

State insulin price cap law cuts out-of-pocket costs by 40%, study finds
Diabetes affects millions of Americans, with 1.4 million new cases diagnosed each year. This chronic condition is one of the leading causes of death in the United States and accounts for more than $320 billion in annual health care costs.
September 9th, 2024 — Source

Systemic glucocorticoid use doubles risk of developing diabetes
glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) will hear.
September 9th, 2024 — Source

Weight loss interventions may lower risk of severe infections in diabetics
Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) suggests.
September 9th, 2024 — Source

Health — Diabetes — September 6th, 2024

Global study explores the connection between meat consumption and type 2 diabetes risk
Eating red and processed meat ups diabetes risk, but swapping for poultry or unprocessed meat may help lower it slightly.
September 6th, 2024 — Source

Health — Diabetes — September 3rd, 2024

No link found between popular diabetes medication and suicide
There has been concern that common diabetes drugs could increase the risk of suicide and self-harm. In a new study, led by researchers at Karolinska Institutet and published in JAMA Internal Medicine, no such risk increase was observed.
September 3rd, 2024 — Source

Study finds blood fats predict success of dietary weight loss in pre-diabetes management
New research from the Centenary Institute has identified specific blood fats that can predict how effectively individuals with pre-diabetes will improve their blood sugar levels through diet and weight loss. These findings could pave the way for more personalized approaches to preventing and managing type 2 diabetes.
September 3rd, 2024 — Source

Study shows beta cells can function independently for glycemic control
Our glycemic balance is based on the ability of the pancreatic beta cells to detect glucose and secrete insulin to maintain our blood sugar levels. If these cells malfunction, the balance is broken, and diabetes develops.
September 3rd, 2024 — Source

Health — Diabetes — August 31st, 2024

Everything you need to know about insulin
Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively.
August 31st, 2024 — Source

Health — Diabetes — August 27th, 2024

A medical resident bought hair ties for a patient: Her acts of kindness initiative is now expanding to more hospitals
Noor Shaik rushed to the bedside of a patient with severe diabetes complications, who had remained upbeat while undergoing surgery to address a foot infection.
August 27th, 2024 — Source

FDA clears first automated device to deliver insulin to people with type 2 diabetes
The U.S. Food and Drug Administration on Monday approved the expanded use of an automated insulin pump system to include those with type 2 diabetes.
August 27th, 2024 — Source

FDA Clears First Device to Automatically Dose Insulin for Type 2 Diabetes
The FDA has approved Insulet SmartAdjust automatic insulin dosing technology for type 2 diabetes in those aged 18 and older.
August 27th, 2024 — Source

Risk for dementia found to be similar with SGLT2 inhibitors, dulaglutide in type 2 diabetes
For older adults with type 2 diabetes, the risk for dementia seems similar with sodium-glucose cotransporter 2 (SGLT2) inhibitors and the glucagon-like peptide 1 receptor agonist (GLP-1 RA) dulaglutide, according to a study published online Aug. 27 in the Annals of Internal Medicine.
August 27th, 2024 — Source

What is type 1.5 diabetes? It's a bit like type 1 and a bit like type 2—but it's often misdiagnosed
While you're likely familiar with type 1 and type 2 diabetes, you've probably heard less about type 1.5 diabetes.
August 27th, 2024 — Source

Health — Diabetes — August 26th, 2024

Does eating ham, bacon and beef really increase your risk of developing type 2 diabetes?
That lunchtime staple, the humble ham sandwich, has come in for a bashing in the press recently. According to many reports, eating two slices of ham a day can increase your risk of developing type 2 diabetes.
August 26th, 2024 — Source

DexCom launches Stelo, first over-the-counter glucose biosensor in U.S., available without prescription
DexCom, a maker of real-time continuous glucose monitoring devices, announced today the availability of Stelo, the first over-the-counter glucose biosensor in the U.S., now purchasable without a prescription at Stelo.com. This new offering is targeted at the 125 million Americans with Type 2 diabetes and those with prediabetes.
August 26th, 2024 — Source or Source

Findings shed light on the cellular mechanisms causing insulin resistance
Recent research published in the journal Diabetes sheds new light on the cellular mechanisms causing insulin resistance in type 2 diabetes, a disease affecting more than 1.2 million people in Quebec alone.
August 26th, 2024 — Source

Health — Diabetes — August 22nd, 2024

How insulin, zinc and pH can block harmful protein clumps linked to type 2 diabetes
An estimated 462 million people around the world suffer from type 2 diabetes, a chronic disease in which the body has problems using sugar as a fuel, leading to a buildup of sugar in the blood and chronic health issues.
August 22nd, 2024 — Source

Mental health and chronic diabetes complications strongly linked both ways, study finds
Heart attack, stroke, nerve damage. These are just some of the complications for which millions of Americans with diabetes are at greater risk.
August 22nd, 2024 — Source

Study links fine particulate matter exposure to increased risk of gestational diabetes
A recent BMC Public Health study assesses the relationship between exposure to fine particulate matter (PM2.5) and the risk of gestational diabetes mellitus (GDM).
August 22nd, 2024 — Source

Health — Diabetes — August 21st, 2024

Elderly with type 2 diabetes struggle with self-care and medication adherence
As the world's population ages rapidly, the risk of chronic diseases is rising.
August 21st, 2024 — Source

Study finds potential for antidiabetic drugs to modify osteoarthritis risk
In a recent study published in The Lancet EBioMedicine, a team of scientists used Mendelian Randomization analyses to explore whether antidiabetic medications could potentially be used as disease-modifying osteoarthritis drugs or DMOADs for the therapeutic management of osteoarthritis.
August 21st, 2024 — Source

Health — Diabetes — August 16th, 2024

Risk for developing type 1 diabetes doubled with paternal link
Individuals are less likely to have type 1 diabetes if their mother has the condition than if their father is affected, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of Diabetes, being held from Sept. 9 to 13 in Madrid.
August 16th, 2024 — Source

Health — Diabetes — August 14th, 2024

New system offers more reliable, cost-effective solution for continuous glucose monitoring
A team of researchers from the University of California, Los Angeles (UCLA), Texas A&M University (TAMU), and Florida International University (FIU) have unveiled a groundbreaking innovation in diabetes management with the development of a novel continuous glucose monitoring (CGM) system.
August 14th, 2024 — Source

Health — Diabetes — August 8th, 2024

A smartphone health care application is more effective for weight loss among non-walkers
Obesity, a significant risk factor for non-communicable diseases such as type 2 diabetes and cardiovascular disease, poses a considerable global public health challenge. Among the various strategies to combat obesity, weight-loss interventions that offer lifestyle modification guidance through web-based services have attracted attention.
August 8th, 2024 — Source

A third of NHS shakes and soups diet participants achieve diabetes remission
In a recent study published in The Lancet Diabetes & Endocrinology, researchers assessed insulin-independent diabetes remission by total dietary replacement (TDR) in England.
August 8th, 2024 — Source

HbA1c stability tied to lower risk for Alzheimer's disease and related dementias
Increased glycated hemoglobin (HbA1c) stability within patient-specific target ranges is associated with a lower risk for Alzheimer's disease and related dementias (ADRD), according to a study published online Aug. 2 in JAMA Network Open.
August 8th, 2024 — Source

How Little Denmark Got Homegrown Giant Novo Nordisk To Lower Ozempic Prices
On May 13, Sen. Bernie Sanders (I-Vt.) published an open letter to Novo Nordisk on the front page of a leading Danish newspaper, urging the hometown company to live up to its altruistic standards by lowering U.S. prices for its blockbuster diabetes and weight loss drugs.
August 8th, 2024 — Source

Prenatal famine exposure tied to higher risk of Type 2 diabetes
Researchers at Columbia University Mailman School of Public Health, the University of North Carolina at Chapel Hill and at the National Academy of Sciences of Ukraine used the setting of the man-made Ukrainian Holodomor famine of 1932-1933 to examine the relation between prenatal famine and adult Type 2 diabetes mellitus (T2DM).
August 8th, 2024 — Source

Proteomic insights reveal key strategies to extend broccoli's freshness and shelf life
A research team has investigated proteome-level changes in harvested broccoli florets stored at room temperature and refrigerated conditions using Tandem Mass Tag (TMT) technology. Their findings reveal that cold storage temperatures reduce protein degradation pathways and key metabolic activities, including autophagy and carbon metabolism.
August 8th, 2024 — Source

Researchers find type 2 diabetes cases more than doubled seven decades after exposure to famine
Researchers at Columbia University Mailman School of Public Health, the University of North Carolina at Chapel Hill and at the National Academy of Sciences of Ukraine used the setting of the man-made Ukrainian Holodomor famine of 1932--1933 to examine the relation between prenatal famine and adult type 2 diabetes mellitus (T2DM).
August 8th, 2024 — Source

Study reveals ways in which 40Hz sensory stimulation may preserve brain's 'white matter'
Early-stage trials in Alzheimer's disease patients and studies in mouse models of the disease have suggested positive impacts on pathology and symptoms from exposure to light and sound presented at the gamma band frequency of 40 Hz.
August 8th, 2024 — Source

Health — Diabetes — August 6th, 2024

CT health screening can identify diabetes risk
Analysis of CT scans in people who undergo imaging for health screening can identify individuals at risk of type 2 diabetes, according to a study published today in Radiology. Researchers said the findings underscore CT's value in opportunistic imaging—the use of information from routine imaging examinations to learn more about a patient's overall health.
August 6th, 2024 — Source

Health — Diabetes — July 31st, 2024

Unique mechanism protects pancreatic cells from inflammation in mice
Researchers from the University of Cologne have revealed a mechanism protecting pancreatic &beta-cells, which are crucial for insulin production from inflammatory cell death. The study investigated the role of receptor-interacting protein kinase 1 (RIPK1) in regulating &beta-cell survival.
July 31st, 2024 — Source

Health — Diabetes — July 26th, 2024

Recent advances show promise in stemming the growing prevalence of diabetes
A study surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing targeted interventions to reduce the risk of developing diabetes and managing its complications.
July 26th, 2024 — Source

Health — Diabetes — July 24th, 2024

Long-term sulfonylurea use tied to impaired awareness of hypoglycemia
The prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of the Annals of Family Medicine.
July 24th, 2024 — Source

Prediabetes remission for type 2 diabetes prevention: Researchers advocate normalization of blood sugar regulation
Current medical guidelines recommend that people in a preliminary stage of type 2 diabetes lose at least 7% of their body weight in order to prevent manifest diabetes.
July 24th, 2024 — Source

Health — Diabetes — July 22nd, 2024

Apple Watch 10 X blood sugar sensor
In recent years, wearable technology has made significant strides in enhancing personal health monitoring. Apple, a forerunner in this domain, continues to push the boundaries with its innovative Apple Watch series. Among the highly anticipated features rumored to be in development is a blood sugar sensor, a potential game-changer for individuals managing diabetes and those keen on maintaining optimal health.
July 22nd, 2024 — Source

Diabetes and obesity can cause liver failure—but few people know their risk of developing liver disease
Liver disease is frighteningly common worldwide.
July 22nd, 2024 — Source

Health — Diabetes — July 18th, 2024

Accelerated progression to T1D during pandemic seen for presymptomatic youth
For youth with presymptomatic type 1 diabetes, the COVID-19 pandemic was associated with accelerated progression to clinical disease, especially among those with COVID-19 infection, according to a research letterpublished online July 15 in the Journal of the American Medical Association.
July 18th, 2024 — Source

Unhealthy sleep linked to diabetes in a diverse population
Persistently unhealthy sleep, either not enough or too much, is associated with a significantly increased risk of Type 2 diabetes in a racially and economically diverse adult population, an international team of researchers has reported.
July 18th, 2024 — Source or Source

Health — Diabetes — July 9th, 2024

Exploring the link between lifestyle patterns and depression in diabetic individuals
In a recent study published in BMC Public Health, researchers investigated the impact of lifestyle patterns and diet on depression in individuals with diabetes.
July 9th, 2024 — Source

Semaglutide found to cut major adverse cardiovascular events in people with overweight, obesity
Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.
July 9th, 2024 — Source

Health — Diabetes — July 6th, 2024

Diabetes drugs like Ozempic lower cancer risks: Study
A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
July 6th, 2024 — Source

Health — Diabetes — July 5th, 2024

From banning junk food ads to a sugar tax: With diabetes on the rise, Australia can't afford to ignore the evidence
There are renewed calls this week for the Australian government to implement a range of measures aimed at improving our diets. These include restrictions on junk food advertising, improvements to food labeling, and a levy on sugary drinks.
July 5th, 2024 — Source

Regulatory and psychological considerations of CGM use in people not living with diabetes
A new narrative review led by researchers at UCL and Birmingham Children's Hospital has found there is a lack of evidence to demonstrate the effective use of continuous glucose monitors (CGMs) in people not living with diabetes (PNLD).
July 5th, 2024 — Source

Health — Diabetes — July 2nd, 2024

Doctors could soon use facial temperature for early diagnosis of metabolic diseases
A colder nose and warmer cheeks may be a telltale sign of rising blood pressure. Researchers discovered that temperatures in different face regions are associated with various chronic illnesses, such as diabetes and high blood pressure. These temperature differences are not easily perceptible by one's own touch but can instead be identified using specific AI-derived spatial temperature patterns that require a thermal camera and a data-trained model.
July 2nd, 2024 — Source

Research shows how insulin-triggering nutrients vary from person to person, with implications for personalized nutrition
When it comes to managing blood sugar levels, most people think about counting carbs. But new research from the University of British Columbia shows that, for some, it may be just as important to consider the proteins and fats in their diet.
July 2nd, 2024 — Source

Health — Diabetes — June 28th, 2024

Blood Sugar Tracking Heats Up: FDA Clears 2 New Monitors, Another to Roll Out This Summer
Prescription-free continuous glucose monitors will be more widely available very soon. Here's what to know.
June 28th, 2024 — Source

Researchers discover molecule's ability to suppress negative effects of type 2 diabetes, obesity
Researchers from Children's Hospital of Philadelphia (CHOP) revealed the mechanisms behind one particular molecule's involvement in regulating insulin sensitivity. The findings, which were translated from a preclinical animal model into a human study, may serve as the basis for a potential therapeutic target for obesity-related type 2 diabetes.
June 28th, 2024 — Source

Health — Diabetes — June 26th, 2024

Cortisol might play role in tough-to-treat diabetes
The stress hormone cortisol appears to play a role in tough-to-treat type 2 diabetes, a new study finds.
June 26th, 2024 — Source

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study
A recent study published in eClinical Medicine compares the effectiveness of anti-diabetes medications in reducing the risk of dementia in older diabetics.
June 26th, 2024 — Source

Exposure to plastics chemical BPA may raise diabetes risk
People fed small doses of Bisphonol A (BPA) developed significantly worse insulin sensitivity within a four-day period, researchers found.
June 26th, 2024 — Source

Molecular mapping reveals tissue-specific gene regulation by diabetes-linked transcription factors
Scientists have generated a comprehensive map of the gene targets regulated by the transcription factors HNF4A and HNF1A in human pancreatic beta cells and liver cells. Published in the journal Nature Communications, the study revealed common and tissue-specific molecular pathways regulated by HNF4A and HNF1A, two proteins that possess important functions governing the development and function of the pancreas and liver.
June 26th, 2024 — Source

Study finds women lost more of their body weight on average with semaglutide than men
In a recent study published in The Journal of the American College of Cardiology, researchers performed a secondary analysis of the semaglutide treatment effect in people with obesity and heart failure with a preserved left ventricular ejection fraction (STEP-HFpEF) program that included individuals with diabetes mellitus (STEP-HFpEF DM), stratified by biological sex.
June 26th, 2024 — Source

Health — Diabetes — June 24th, 2024

Circulating microRNAs likely as effective as A1C for predicting type 2 diabetes in youth
Type 2 diabetes in young people ages 10 to 19 has more than doubled in the past 20 years, yet it remains difficult for physicians to predict who will be diagnosed and who will improve with treatment. A new study shows that measuring the circulating abundance of microRNAs -- which affect insulin-producing beta cells in the pancreas -- is likely as effective as measuring the level of sugar in the blood for determining how a young person with the condition will fare.
June 24th, 2024 — Source or Source

Cholesterol-lowering drug slows progression of eye disease in people with diabetes: Clinical trial
The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%. The results were announced at the American Diabetes Association Scientific Sessions and published in a paper titled, "Effect of Fenofibrate on Progression of Diabetic Retinopathy," published in NEJM Evidence.
June 24th, 2024 — Source

Novel blood-powered chip offers real-time health monitoring
Metabolic disorders, like diabetes and osteoporosis, are burgeoning throughout the world, especially in developing countries.
June 24th, 2024 — Source

Targeting the gut microbiome: A new approach to treating diabetes
A recent Nutrients study reviews the crucial role of gut microbiota in the pathogenesis and management of diabetes mellitus (DM).
June 24th, 2024 — Source

Health — Diabetes — June 22nd, 2024

Apple-blueberry cobbler
Whole-wheat flour includes the nutritious wheat germ and bran coating of the grain. Besides adding fiber, whole-wheat flour gives a nutty taste and coarser texture. To make this plant based, use a milk substitute.
June 22nd, 2024 — Source

Beet burgers
This veggie burger provides about one-third of your daily fiber needs. Be sure to top it with even more veggies.
June 22nd, 2024 — Source

Best Vegan Meal Delivery Services for 2024
After extensive research and testing, here are CNET's top picks of the best vegan meal delivery subscriptions.
June 22nd, 2024 — Source

Quesadillas
Tortillas come in two basic types: corn and wheat. If you decide to use wheat tortillas, choose the whole wheat kind. They're made from whole-grain flour. They have more fiber than wheat tortillas made from white flour, also called "flour tortillas."
June 22nd, 2024 — Source

Raspberry chocolate scones
A scone is a quick bread. This version uses less butter than a typical scone recipe.
June 22nd, 2024 — Source

Shrimp and artichoke pasta
Dietitian's tip: This light version of shrimp salad has no mayo in it. But it's filling enough to be served as an entree.
June 22nd, 2024 — Source

Veggie egg bake
Dietitian's tip: You can prepare this casserole and store it in the fridge overnight. The next morning, let the casserole stand at room temperature while the oven heats. Then bake it as directed.
June 22nd, 2024 — Source

Weight loss: 6 strategies for success
Follow these proven ways to lose weight and boost your health.
June 22nd, 2024 — Source

Health — Diabetes — June 21st, 2024

Semaglutide weight loss results linked to diabetes severity
In a recent study published in eClinicalMedicine, researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetespatients with type 2 diabetes (T2D) based on their individualized metabolic surgery (IMS) score.
June 21st, 2024 — Source

Health — Diabetes — June 20th, 2024

Exercising at night improves glucose control in overweight adults
A recent study published in Obesity explores differences in the timing of moderate-to-vigorous physical activity (MVPA) and its impact on blood glucose levels and metabolic function in overweight and obese sedentary adults.
June 20th, 2024 — Source

Gestational diabetes: Research identifies new subgroups that improve personalized therapy
Patients with gestational diabetes show different disease progressions and therefore require personalized treatment measures. An international research team led by MedUni Vienna has now identified three subgroups of the disease with different treatment needs.
June 20th, 2024 — Source

WHO issues medical product alert on falsified semaglutides
The World Health Organization (WHO) issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of type 2 diabetes and obesity in some countries.
June 20th, 2024 — Source

Health — Diabetes — June 14th, 2024

New approach against fatty liver: Molecular pathway identified
Fatty liver disease (SLD) is increasingly causing failure of the liver as a vital organ. A team led by researchers from the Institute of Metabolic Physiology at Heinrich Heine University Düsseldorf (HHU) in collaboration with the German Diabetes Center (DDZ) and other partners has now discovered that a saturated fatty acid in blood vessels leads to the production of the signaling molecule SEMA3A, which closes the "windows" in the blood vessels. This hinders the transport of fat from the liver to the adipose tissue.
June 14th, 2024 — Source

New recommendations on vitamin D intake for children, pregnant people, adults over 75 and those with high-risk prediabetes
In a recent study published in The Journal of Clinical Endocrinology & Metabolism, researchers developed therapeutic recommendations for utilizing vitamin D [cholecalciferol (vitamin D3) or ergocalciferol (vitamin D2)] to reduce the risk of illness in individuals who do not have documented grounds for vitamin D medication or 25-hydroxyvitamin D [25(OH)D] testing.
June 14th, 2024 — Source

Researchers unveil impact of east Asian gene variant on type 2 diabetes risk
It was earlier discovered that a variation in the PAX4 gene specifically predisposes East Asians to a higher risk of developing type 2 diabetes (T2D), increasing lifetime risk by up to 1.8 times. A new study, now published in the journal Nature Communications, reveals for the first time how an East Asian-specific PAX4 gene variant, R192H, impacts the development and function of beta cells in the pancreas.
June 14th, 2024 — Source

Health — Diabetes — June 12th, 2024

Gastric bypass maintains weight loss and diabetes remission over 15 years, study shows
Roux-en-Y gastric bypass, a type of weight-loss surgery, kept type 2 diabetes in remission for up to 15 years and most of the weight off for up to 20 years in one of the largest long-term studies of patients undergoing the procedure. The study was presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting.
June 12th, 2024 — Source or Source

Health — Diabetes — June 10th, 2024

For type 1 diabetes distress, researchers say focus first on managing emotions
The most effective way to reduce the distress that comes with having diabetes—and improve glucose control—is to focus on managing the emotional strain of living with the condition, a new study of adults that was led by researchers at UC San Francisco has found.
June 10th, 2024 — Source

Health — Diabetes — June 7th, 2024

Antioxidant gel preserves islet function after pancreas removal: New approach could reduce diabetes complications
Northwestern University researchers have developed a new antioxidant biomaterial that someday could provide much-needed relief to people living with chronic pancreatitis.
June 7th, 2024 — Source

New therapeutic targets to fight type 2 diabetes
One of the most confusing aspects for patients with type 2 diabetes mellitus is that they have high fasting glucose levels. This is because in these insulin-resistant patients, glucose production by the liver is triggered, a process that is still full of questions for the scientific community.
June 7th, 2024 — Source

Oral insulin drops offer relief for diabetes patients
Sublingual drops easily and efficiently absorbed by the body, potentially replacing insulin injections
June 7th, 2024 — Source

Researchers determine timing is key for type 2 diabetes drug performance
Researchers from the University of Adelaide could be closer to discovering a better way to use metformin, a common type 2 diabetes medication.
June 7th, 2024 — Source

Health — Diabetes — June 6th, 2024

Study shows orexin neurons can track how fast blood glucose changes
The concentration of glucose in the blood of humans continuously changes in response to what they eat and the activities they engage in. While many studies have investigated changes in blood glucose, the role of different neurons in tracking and predicting these changes remains poorly understood.
June 6th, 2024 — Source

Health — Diabetes — May 31st, 2024

A nanomaterial one-two punch quickly heals wounds in diabetic animal model
Wounds that are superficial for some can be life-threatening for others. With diabetic wounds, healing can be slow, particularly in the feet, increasing the tissue's susceptibility to infection. Foot ulcers and other diabetic foot complications have similar mortality rates to some cancers, yet progress toward improved treatments has plateaued.
May 31st, 2024 — Source

Health — Diabetes — May 30th, 2024

Demographic, clinical, financial factors tied to GLP-1 agonist discontinuation
Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in JAMA Network Open.
May 30th, 2024 — Source

Genetic link between diabetes and gut health could offer treatment solutions
Researchers at Edith Cowan University's (ECU's) Center for Precision Health have uncovered a significant genetic connection between type 2 diabetes and certain gut disorders, which could pave the way for more effective therapies.
May 30th, 2024 — Source

New study highlights senescent cell removal mechanisms of canagliflozin, a sodium glucose co-transporter 2 inhibitor
Aging-related physiological decline and the accumulation of senescent or aging cells in bodily tissues can trigger a number of diseases. The removal of senescent cells, also known as "senolysis," can therefore serve as an effective strategy against aging-related diseases.
May 30th, 2024 — Source

Health — Diabetes — May 29th, 2024

High price of popular diabetes drugs deprives low-income people of effective treatment
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions for the medications they need to control their blood sugar.
May 29th, 2024 — Source

Microplastics: Invisible to the eye but severely harmful to pregnancy and metabolic outcomes
In a recent study published in Ecotoxicology and Environmental Safety, researchers aimed to investigate the effects of polystyrene microplastics on pregnancy outcomes and glucose metabolism.
May 29th, 2024 — Source

Health — Diabetes — May 28th, 2024

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings NewsGuard 100/100 Score
In a recent study published in the Journal of Clinical Medicine, a group of researchers described the clinical characteristics of patients with type 2 diabetes (T2D) initiating oral semaglutide and assessed its effects on glycemic control, body weight (BW), and tolerability in routine clinical practice.
May 28th, 2024 — Source

Taking semaglutide once weekly may lower the chances of kidney disease, says study
In a recent study published in Kidney International Reports, researchers investigated the effects of semaglutide (administered once weekly) on kidney disease outcomes and changes in KDIGO (short for kidney disease improving global outcomes) risk categories in participants with type 2 diabetes (T2D) and established cardiovascular disease (CVD) or high cardiovascular (CV) risk.
May 28th, 2024 — Source

Health — Diabetes — May 24th, 2024

Century-old vaccine protects type 1 diabetics from infectious diseases
Researchers conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Gu rin (BCG) vaccine in people with type 1 diabetes during the COVID-19 pandemic.
May 24th, 2024 — Source

Early intensified treatment cuts type 2 diabetes burden by USD 23 million in Korea
A recent study by WifOR Institute highlights the societal benefits of early intensified treatment for Type 2 diabetes patients in Korea. Over a 10-year period,12% more patients who started combination therapy during the early stages of the disease achieved sustained glycemic control compared to those who began with monotherapy.
May 24th, 2024 — Source

Research finds connection between risk factors for periodontitis and general health
Periodontitis is a disease that affects the supporting tissues of the teeth and is associated with other types of diseases. A study conducted at the faculty of dentistry shows that patients with severe periodontitis also have a higher prevalence of cardiovascular disease, diabetes, and COPD.
May 24th, 2024 — Source

Type 2 diabetes treatment found to impact fungal community in human gut
Metabolic diseases, such as type 2 diabetes, are associated with compositional shifts in the human gut microbiome, including the fungal fraction called the mycobiome. But research on the mycobiome and how type 2 diabetes or its common treatment, metformin, may interact remains relatively limited despite suggestions that these fungi can influence the overall health of the microbiome, according to a research team at Penn State.
May 24th, 2024 — Source

Health — Diabetes — May 23rd, 2024

Exposure to endocrine-disrupting chemicals in utero associated with higher odds of metabolic syndrome in children
The term 'metabolic syndrome' (MetS) encompasses a group of factors, such as abdominal obesity, hypertension and insulin resistance, that together increase the risk of cardiovascular disease and type 2 diabetes.
May 23rd, 2024 — Source

The next food marketing blitz is aimed at people on new weight-loss drugs
Taking a weight-loss drug? Food makers have just the new food for you.
May 23rd, 2024 — Source

Health — Diabetes — May 17th, 2024

Anti-diabetic treatment associated with reduced risk of developing blood cancer
People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according to a study published in Blood Advances.
May 17th, 2024 — Source or Source

Men face greater risk of cardiovascular and kidney issues due to diabetes, study shows
In a recent study published in the Journal of Epidemiology and Community Health, researchers investigated gender disparities in microvascular and macrovascular complication rates among individuals with diabetes.
May 17th, 2024 — Source

Health — Diabetes — May 13th, 2024

Higher blood sugar level at gestational diabetes diagnosis linked to harmful outcomes for mothers and babies
The higher the blood sugar level in pregnant women when first diagnosed with diabetes, the higher the risk of complications around and after birth, according to research presented at the 26th European Congress of Endocrinology, held 11--14 May in Stockholm.
May 13th, 2024 — Source

Improving the safety of iPS cell-derived pancreatic islets by eliminating unwanted cells
A team of researchers has uncovered the identity of off-target cells responsible for abnormal outgrowth and devised a method to eliminate them from iPS cell-derived pancreatic tissues in development for cell therapy against type 1 diabetes.
May 13th, 2024 — Source

Health — Diabetes — May 10th, 2024

Researchers quantify the risk for diabetes after gestational diabetes
Gestational diabetes is associated with an increased risk for subsequent diabetes, with higher risk for gestational diabetes in second pregnancy and in both first and second pregnancies, according to a study published online May 9 in JAMA Network Open.
May 8th, 2024 — Source

Health — Diabetes — May 1st, 2024

Short and long sleep durations associated with higher diabetes incidence, study finds
In a recent study published in BMC Medicine, a group of researchers identified plasma proteomic patterns associated with sleep duration and evaluated their impact on the risk of developing diabetes mellitus (DM) and coronary heart disease (CHD).
May 1st, 2024 — Source

Health — Diabetes — April 30th, 2024

Specific class of drugs can reverse diet-induced obesity, fatty liver and diabetes in mice
Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' powerhouses, the mitochondria. A study published in Nature Metabolism shows that a specific class of drugs that block mitochondrial function can reverse diet-induced obesity, fatty liver and diabetes in mice.
April 30th, 2024 — Source

What is blood glucose tracking and can the Apple Watch do it?
The challenges of blood glucose monitoring.
April 30th, 2024 — Source

Health — Diabetes — April 26th, 2024

High-precision blood glucose level prediction achieved by few-molecule reservoir computing
(Nanowerk News) A collaborative research team from NIMS and Tokyo University of Science has successfully developed a cutting-edge artificial intelligence (AI) device that executes brain-like information processing through few-molecule reservoir computing.
April 26th, 2024 — Source or Source

Pre-Ozempic Obesity Drugs: Effective and Budget-Friendly
Before there was Ozempic, Wegovy, or Zepbound, there were cost-friendly, safe, and effective weight loss drugs. FDA-approved obesity medication like orlistat (brand name: Xenical), phentermine/topiramate (Qsymia), and naltrexone/bupropion extended release (Contrave) have been on the market for decades.
April 26th, 2024 — Source

Samsung may bring blood sugar monitoring with Galaxy Watch 7
Samsung‘s upcoming smartwatches may bring a revolutionary health feature. According to the Korean media, the Galaxy Watch 7 series will boast noninvasive blood sugar monitoring capabilities. The new watches are expected to arrive in July this year.
April 26th, 2024 — Source

Health — Diabetes — April 22nd, 2024

Innovative shoe insole technology mitigates the risk of diabetic foot ulcers NewsGuard 100/100 Score
Researchers have developed a new shoe insole technology that helps reduce the risk of diabetic foot ulcers, a dangerous open sore that can lead to hospitalization and leg, foot or toe amputations.
April 22th, 2024 — Source

New findings on pancreatic anatomy may affect diabetes research and treatment
Researchers at Umeå University have succeeded in imaging an entire human organ, a pancreas, in microscopic resolution. By staining different cell-types with antibodies and then using optical 3D imaging techniques to study the entire organ, their data provides a partially new picture of the pancreas.
April 22th, 2024 — Source

Health — Diabetes — April 19th, 2024

Three ways to improve diabetes care through telehealth
Grocery stores, airports and beaches aren't great places to have telehealth visits with your endocrinologist. But home can be one of the best locations, giving a doctor helpful insights into a patient's home environment, which can positively impact their care.
April 19th, 2024 — Source

Type 2 diabetes is not one-size-fits-all: Subtypes affect complications and treatment options
You may have heard of Ozempic, the "miracle drug" for weight loss, but did you know that it was actually designed as a new treatment to manage diabetes? In Canada, diabetes affects approximately 10% of the general population. Of those cases, 90% have type 2 diabetes.
April 19th, 2024 — Source

Shoe technology helps reduce risk of diabetic foot ulcers
Researchers have developed a new shoe insole technology that helps reduce the risk of diabetic foot ulcers, a dangerous open sore that can lead to hospitalization and leg, foot or toe amputations.
April 19th, 2024 — Source

Health — Diabetes — April 17th, 2024

1 in 5 older Canadian adults with diabetes developed functional limitations during the pandemic
Researchers found that approximately 1 in 5 older Canadian adults with diabetes and no pre-pandemic functional limitations developed functional limitations for the first time during the COVID-19 pandemic. Functional limitations refer to difficulties with basic mobility-related tasks, such as walking two to three blocks, standing up from a chair, or climbing stairs.
April 17th, 2024 — Source or Source

Bariatric surgery-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure: Study
Bariatric surgery has emerged as an effective means of reducing weight in morbidly obese individuals, while also significantly improving diabetes. Currently, laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) are two of the most commonly performed bariatric surgeries.
April 17th, 2024 — Source

Best Continuous Glucose Monitors of 2024
Continuous glucose monitors help you track your blood sugar and manage your diabetes. Here are our picks for the top continuous glucose monitors of 2024.
April 17th, 2024 — Source

Could lack of sleep increase your risk of type 2 diabetes?
Not getting enough sleep is a common affliction in the modern age. If you don't always get as many hours of shut-eye as you'd like, perhaps you were concerned by news of a recent study that found people who sleep less than six hours a night are at higher risk of type 2 diabetes.
April 17th, 2024 — Source

Researchers find glucose levels of nondiabetic people vary more than thought
A medical researcher at Tel Aviv University, working with a group of computer scientists at the Weizmann Institute of Science, both in Israel, has found that fasting glucose levels in nondiabetic people vary more than previously thought.
April 17th, 2024 — Source

Health — Diabetes — April 15th, 2024

Fact check: Biden is right about $35 insulin cap but exaggerates prior costs for Medicare enrollees
Insulin for Medicare beneficiaries "was costing 400 bucks a month on average. It now costs $35 a month."
April 15th, 2024 — Source

Moderate vitamin E, C, and &beta-carotene intake reduces type 2 diabetes risk
In a recent study published in Advances in Nutrition, researchers review the effect of vitamins C and E, as well as &beta-carotene, on the risk of type 2 diabetes (T2D).
April 15th, 2024 — Source

Study finds inverse association between weight loss drugs and multiple sclerosis
Initially, diabetes drugs like Ozempic and Wegovy showed promise in weight loss and have subsequently been marketed and widely used for weight loss. Now these medications are showing promise as a possible treatment for multiple sclerosis.
April 15th, 2024 — Source

Health — Diabetes — April 12th, 2024

Fully printed wearable biosensor tracks glucose, alcohol, pH and temperature in sweat
Imagine a future where a simple patch worn on the skin could keep tabs on your health as you go about your day, flagging concerning changes before symptoms even appear. This tantalizing vision has driven intense research into wearable biosensors that can non-invasively monitor diverse physiological parameters. While consumer devices like smartwatches can already track basics like heart rate and activity, the next frontier is tapping into the trove of molecular biomarkers carried in bodily fluids like sweat.
April 12th, 2024 — Source

Health — Diabetes — April 11th, 2024

Scientists say outdated diabetes drug still has something to offer
Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease. While TZDs were extremely popular in the 1990s and early 2000s, they have fallen out of use among physicians in recent decades because they were discovered to cause unwanted side effects, including weight gain and excess fluid accumulation in body tissues.
April 11th, 2024 — Source

Study shows effect of socio-economic factors that predict diabetic patients' risk of heart failure
A recent study by Case Western Reserve University used national data from U.S. military veterans with diabetes to validate and modify a widely accepted model used to predict the risk of heart failure in diabetic patients.
April 11th, 2024 — Source

Health — Diabetes — April 10th, 2024

Resistant starch could help combat leading cause of end-stage kidney failure
Combining a low dose of blood pressure medication with a higher intake of dietary-resistant starch might help stave off diabetic kidney disease, according to results from a new animal study. Kidney disease is a common diabetes complication and the leading cause of end-stage kidney failure. Researchers presented their work at the American Physiology Summit, held April 4--7 in Long Beach, California.
April 10th, 2024 — Source

Health — Diabetes — April 5th, 2024

Biden is right about $35 insulin cap but exaggerates prior costs for Medicare enrollees
The cost of insulin in the United States has risen considerably in recent years, with some estimates finding that Americans have paid around 10 times as much for the drug as people in other developed countries.
April 5th, 2024 — Source

Diabetes WA reports hack and more briefs
Also, New Zealand's My Health Record has expanded access to more personal health information.
April 5th, 2024 — Source

Health — Diabetes — April 4th, 2024

Review identifies disrupted mitochondrial metabolism as a trigger for diabetic cardiomyopathy
Diabetes is a global health burden. A whopping 536 million people worldwide struggle with diabetes. Diabetic cardiomyopathy (DC) is a serious condition characterized by impaired heart function due to diabetes-related metabolic abnormalities.
April 4th, 2024 — Source

Health — Diabetes — April 2nd, 2024

Artificial pancreas that pumps insulin into diabetes patients launches on NHS
The smart device can monitor and adjust glucose and insulin levels
April 2nd, 2024 — Source

Pancreas cells in people who have died show significant signs of stress
People with type 1 diabetes require daily insulin shots to regulate their blood sugar levels. This is because their immune system kills beta cells found in islets in the pancreas. Beta cells release and disburse insulin to cells throughout the body. Insulin is needed to break down sugar.
April 2nd, 2024 — Source

The rise of Ozempic: How surprise discoveries and lizard venom led to a new class of weight-loss drugs
Every now and then, scientists develop treatments that end up being even more popular for another condition entirely. Think of Viagra, originally for high blood pressure, now used for erectile dysfunction. Or thalidomide, a dangerous morning sickness treatment that is now a valuable cancer treatment.
April 2nd, 2024 — Source

Health — Diabetes — March 29th, 2024

How might fiber lower diabetes risk? Your gut could hold the clues
Eating more dietary fiber may help prevent type 2 diabetes by promoting beneficial gut bacteria and substances produced during metabolism, according to new research in Hispanic adults.
March 29th, 2024 — Source

Scientists close in on a pain-free method for controlling type 1 diabetes
Lee Calladine pricks his skin with a needle up to eight times a day to give himself an injection of insulin—the hormone that keeps his type 1 diabetes in check. Without insulin, his blood-sugar levels would become dangerously high and eventually fatal.
March 29th, 2024 — Source

UK study identifies ideal weight for adults with type 2 diabetes to minimize risk of dying from cardiovascular disease
New research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12--15 May), identifies the optimum body weight range for adults with type 2 diabetes to minimize their risk of dying from any cardiovascular disease, including heart failure, heart disease, stroke, and chronic kidney disease.
March 29th, 2024 — Source

Understanding diabetic kidney disease
Diabetic nephropathy, also called diabetic kidney disease, is a serious complication of type 1 diabetes and type 2 diabetes. In the U.S., about 1 in 3 people living with diabetes have diabetic nephropathy.
March 29th, 2024 — Source

Health — Diabetes — March 28th, 2024

Clear shift in arterial diseases in diabetes
There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes. The risks of heart attack and stroke have decreased significantly, while complications in more peripheral vessels have increased in relative importance, according to new studies.
March 28th, 2024 — Source

Researchers report clear shift in arterial diseases in diabetes
There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes. The risks of heart attack and stroke have decreased significantly, while complications in more peripheral vessels have increased in relative importance, according to studies at the University of Gothenburg.
March 28th, 2024 — Source

Health — Diabetes — March 27th, 2024

Best Continuous Glucose Monitors of 2024
Continuous glucose monitors help you track your blood sugar and manage your diabetes. Here are our picks for the top continuous glucose monitors of 2024.
March 27th, 2024 — Source

Health — Diabetes — March 25th, 2024

Aspirin cuts liver fat in clinical trial
The most common chronic liver disease—metabolic dysfunction--associated steatotic liver disease (MASLD)—is characterized by an increased buildup of fat in the liver due to factors such as obesity and type 2 diabetes.
March 25th, 2024 — Source

Study adds new evidence on the link between Type 2 diabetes and Alzheimer's disease NewsGuard 100/100 Score
New research conducted in mice offers insights into what's going on at the molecular level that could cause people with diabetes to develop Alzheimer's disease.
March 25th, 2024 — Source

Health — Diabetes — March 22nd, 2024

Scientists close in on TB blood test which could detect millions of silent spreaders
Millions of people are spreading tuberculosis unknowingly - now scientists say they are close to developing a new test that is as simple as the lateral flows used during the Covid pandemic.
March 22nd, 2024 — Source

Health — Diabetes — March 20th, 2024

Exposure to tobacco before birth found to significantly increase risk of type 2 diabetes in adults
Tobacco exposure before birth and beginning smoking during childhood/adolescence were significantly associated with the development of type 2 diabetes in adulthood, especially for people with a high genetic risk of type 2 diabetes, according to preliminary research presented at the American Heart Association's Epidemiology and Prevention│Lifestyle and Cardiometabolic Scientific Sessions 2024, held March 18--21, in Chicago.
March 20th, 2024 — Source

Medications for type 2 diabetes, weight loss and kidney health not always provided as needed
More recent medications for Type 2 diabetes and weight loss shown to have positive effects on cardiovascular and kidney health were not always prescribed or accessible to people who could benefit from them.
March 20th, 2024 — Source

Microneedles offer a promising solution for the treatment of diabetic wounds
The global population of patients with diabetic wounds is expected to rise to between 9.1 million to 26.1 million by 2030. Diabetic wounds severely impact patients' quality of life, both physically and mentally while also imposing a substantial economic burden on healthcare systems.
March 20th, 2024 — Source

Nerve decompression shows promise for diabetic neuropathy patients
Surgical nerve decompression, used to treat conditions such as carpal tunnel syndrome and sciatica, could play a role in relieving the pain of diabetic neuropathy patients, researchers at UT Southwestern Medical Center found.
March 20th, 2024 — Source

Regular intake of sugary drinks, fruit juices tied to higher Type 2 diabetes risk in boys
A small, long-term study of almost 500 children in Massachusetts has found that regularly drinking sugary drinks and 100% fruit juices during childhood and adolescence may be linked to a higher risk of developing Type 2 diabetes among boys than girls, according to preliminary research to be presented at the American Heart Association's Epidemiology and Prevention│Lifestyle and Cardiometabolic Scientific Sessions 2024, March 18- 21, in Chicago.
March 20th, 2024 — Source

Scientists uncover new secrets to natural appetite control, offering promise in the battle against obesity
In a study, just published in Nature Metabolism, scientists from Trinity College Dublin and Princeton and Harvard Medical School share newly uncovered secrets to natural appetite control, which offers promise in the battle against obesity and type-2 diabetes.
March 20th, 2024 — Source

SGLT2i, GLP-1 RA prescribing lower for minority patients
Pharmacy dispensing patterns for sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide 1 receptor agonist (GLP1-RA) medications show lower prescribing for minority patients; and the rate of SGLT2i prescriptions is low among patients with indications for therapy, according to two studies presented at the American Heart Association Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2024 Scientific Sessions, held from March 18 to 21 in Chicago.
March 20th, 2024 — Source

Health — Diabetes — March 15th, 2024

Diabetic neuropathy types: Symptoms tell the story
When you have diabetes, nerve damage called diabetic neuropathy can happen due to high blood sugar. There are four main types of diabetic neuropathy. You may have just one type. Or you may have symptoms of more than one type. Most types of diabetic neuropathy develop over time. So you might not notice symptoms until lots of nerve damage has happened.
March 14th, 2024 — Source

FDA gets granular with draft medical device premarket approval update
The agency further defines when it considers a device to be Internet-enabled, proposes to add vulnerability disclosures and makes recommendations for cyber device maintenance plans and patch timelines.
March 14th, 2024 — Source

New Nanodialysis Device Tracks Chemical Content of Biological Tissue With Sub-Second Resolution
Longstanding challenges in biomedical research such as monitoring brain chemistry and tracking the spread of drugs through the body require much smaller and more precise sensors. A new nanoscale sensor that can monitor areas 1,000 times smaller than current technology and can track subtle changes in the chemical content of biological tissue with sub-second resolution, greatly outperforming standard technologies.
March 14th, 2024 — Source

Researchers develop mobile app to help diabetic patients monitor foot health
A group of researchers, led by Nanyang Technological University, Singapore (NTU Singapore), has developed a mobile application to educate individuals living with diabetes and their caregivers with knowledge of the disease and assist them in monitoring their day-to-day activities, which includes medication, physical activity, and their diet.
March 14th, 2024 — Source

Health — Diabetes — March 14th, 2024

Milestone in diabetes treatment: Transgenic cow produces human insulin in milk
An unassuming brown bovine from the south of Brazil has made history as the first transgenic cow capable of producing human insulin in her milk. The advancement, led by researchers from the University of Illinois Urbana-Champaign and the Universidade de São Paulo, could herald a new era in insulin production, one day eliminating drug scarcity and high costs for people living with diabetes.
March 14th, 2024 — Source

Physician advises diabetics to heed FDA's smart device warning
The FDA has warned diabetes patients not to use smartwatches or smart rings to measure their blood glucose levels. Now, obesity medicine expert Eleanor Yusupov, D.O., assistant professor at New York Institute of Technology College of Osteopathic Medicine, is sharing insight for these patients.
March 14th, 2024 — Source

Health — Diabetes — March 8th, 2024

Comparing pregnancy rates in patients undergoing two types of dialysis
Among patients with end-stage kidney disease (ESKD) on home dialysis, pregnancy rates are higher with home hemodialysis than peritoneal dialysis, according to new research from the University of Cincinnati.
March 8th, 2024 — Source

Diabetes drug dulaglutide may reduce symptoms of depression
A recent Brain and Behavior study investigated the antidepressant effect of dulaglutide and the mechanism that underlies this effect.
March 8th, 2024 — Source

People with diabetes who live in rural areas more likely to develop complications of the disease, study finds
It has been well established that people who live in rural areas in the U.S. are more likely to have diabetes and experience barriers to managing their condition compared to those who live in the suburbs and cities. Now, University of Maryland School of Medicine researchers have measured the devastating toll of this health disparity.
March 8th, 2024 — Source

Health — Diabetes — March 6th, 2024

Data provide new perspective for understanding the antidepressant-like effects of a diabetes drug
Research in animals has shown that the diabetes drug dulaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist may reduce symptoms of depression. A new study published in Brain and Behavior reveals the mechanisms that are likely involved.
March 6th, 2024 — Source

FDA approves the first over-the-counter continuous glucose monitor
It will be available starting this summer.
March 6th, 2024 — Source

Has Medicaid expansion affected pregnancy outcomes among women with gestational diabetes?
The Affordable Care Act (ACA) aims to broaden health care access, but its effect on maternal and newborn health among women with gestational diabetes—or diabetes that develops during pregnancy—across diverse demographics is unclear.
March 6th, 2024 — Source

Uncovering the cyclization mechanism of cyclic &beta-1,2-glucan synthase
The polysaccharide &beta-1,2-glucan consists of repeating units of glucose linked together by &beta-1,2-glycosidic bonds. Cyclic &beta-1,2-glucans (C&betaGs) occur in different bacterial species and have a role in bacterial infections and symbiotic relationships. C&betaG biosynthesis is catalyzed by cyclic &beta-1,2-glucan synthase (CGS), an enzyme that catalyzes the cyclization (closed ring formation) of linear &beta-1,2-glucan (L&betaG).
March 6th, 2024 — Source

Weight loss and diabetes management drug linked to increased residual gastric content before anesthesia
Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published in JAMA Surgery.
March 6th, 2024 — Source

Health — Diabetes — March 4th, 2024

Indonesia can expand its gastrodiplomacy via plant-based meals in Europe
Gastrodiplomacy as the practice of a country's diplomacy by promoting its cuisine, is now gaining popularity in several countries across the globe, including South Korea and Thailand.
March 4th, 2024 — Source

Health — Diabetes — March 1st, 2024

Common anti-diabetic drug shows potential in improving outcome after stroke
People with type 2 diabetes have an increased risk of stroke and a worsened outcome after suffering from it. Now, researchers at the Karolinska Institutet have shown that stroke outcome is significantly improved in mice with obesity and type 2 diabetes who have been treated with the commonly used diabetic drugs SGLT-2 inhibitors.
March 1st, 2024 — Source

Discovery of proteins associated with the progression of dialysis-related amyloidosis
Dialysis patients often develop dialysis-related amyloidosis and exhibit bone and joint disorders that impair their activity of daily living. Blood purification devices consisting of hexadecyl-immobilized cellulose beads aimed at removing the precursor protein, &beta2- microglobulin (&beta2-m), are used in the treatment of dialysis-related amyloidosis.
March 1st, 2024 — Source

Expanding the living kidney donor pool to those with Type 2 diabetes
With more than 90,000 people in the U.S. awaiting kidney transplants, the demand exceeds the available supply—emphasizing the critical importance of identifying safe ways to broaden the kidney donor pool.
March 1st, 2024 — Source

Diabetes: Treating Wounds and Injuries
No matter how small or superficial a wound is, you should not ignore it if you have diabetes, says Daniel Cohen, DPM, a podiatrist with Medical Associates of Brevard in Brevard County, Fla. If you stub your toe, get a blister from tight shoes, or nick your chin while shaving, you probably give it little thought. But if you have diabetes, you should seek proper treatment.
Provides Information — Source